Illinois Municipal Retirement Fund Biomarin Pharmaceutical Inc Transaction History

Illinois Municipal Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$82.16 - $96.94 $526,234 - $620,900	6,405 New	6,405 $543,000
Q2 2021 Aug 04, 2021	SELL	$75.51 - $84.79 $451,474 - $506,959	-5,979 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$72.61 - $90.2 $193,650 - $240,563	2,667 Added 80.53%	5,979 $524,000
Q3 2020 Nov 03, 2020	BUY	$71.87 - $131.03 $238,033 - $433,971	3,312 New	3,312 $252,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Illinois Municipal Retirement Fund with notifications on news.